Proponency Office for Rehabilitation and Reintegration, Office of the Surgeon General, 5109 Leesburg Pike, Suite 684, Falls Church, VA 22041-3258, USA.
Breast Cancer Res Treat. 2010 Feb;120(1):135-47. doi: 10.1007/s10549-009-0710-9.
In order to determine the extent and time course of upper limb impairment and dysfunction in women being treated for breast cancer (BC), and followed prospectively, a novel physical therapy surveillance model post-treatment was used. Subjects included adult women with newly diagnosed, untreated, unilateral, Stage I to III BC, and normal physiological and biomechanical shoulder function. Subjects were excluded if they had a previous history of BC, or prior injury or surgery of the affected upper limb. Measurements included body weight, shoulder ranges of motion (ROM), manual muscle tests, pain levels, upper limb volume, and an upper limb disability questionnaire (ULDQ). Measurements were taken at baseline (pre-surgery), and 1, 3-6, and 12 months post-surgery. All subjects received pre-operative education and exercise instruction and specific physical therapy (PT) protocol after surgery including ROM and strengthening exercises. All measures of function were significantly reduced 1 month post-surgery, but most recovered to baseline levels by 1-year post-surgery. Some subjects developed signs of lymphedema 3-12 months post-surgery, but this did not compromise function. Shoulder abduction, flexion, and external rotation, but not internal rotation ROM, were associated with the ULDQ. Most women in this cohort undergoing surgery for BC who receive PT intervention may expect a return to baseline ROM and strength by 3 months. Those who do not reach baseline, often continue to improve and reach their pre-operative levels by 1-year post-surgery. Lymphedema develops independently of shoulder function 3-12 months post-surgery, necessitating continued monitoring. A prospective physical therapy model of surveillance allows for detection of early and later onset of impairment following surgery for BC in this specific cohort of patients.
为了确定接受乳腺癌(BC)治疗并进行前瞻性随访的女性上肢损伤和功能障碍的程度和时间进程,我们使用了一种新的治疗后物理治疗监测模式。研究对象包括新诊断为单侧 I 期至 III 期、无生理和生物力学肩部功能异常的成年女性 BC 患者。如果患者有 BC 病史、上肢先前受伤或手术史,则将其排除在外。测量包括体重、肩部活动范围(ROM)、徒手肌力测试、疼痛程度、上肢体积和上肢残疾问卷(ULDQ)。在基线(术前)、术后 1、3-6 和 12 个月进行测量。所有患者均接受术前教育和运动指导以及术后特定的物理治疗(PT)方案,包括 ROM 和强化运动。术后 1 个月,所有功能测量均显著降低,但大多数在术后 1 年恢复到基线水平。部分患者在术后 3-12 个月出现淋巴水肿迹象,但未影响功能。肩外展、前屈和外旋,而非内旋 ROM,与 ULDQ 相关。在接受 BC 手术并接受 PT 干预的患者中,大多数女性可能期望在 3 个月内恢复到基线 ROM 和力量。那些未达到基线的患者,通常会继续改善并在术后 1 年达到术前水平。淋巴水肿在术后 3-12 个月独立于肩部功能发生,需要持续监测。前瞻性物理治疗监测模式可在特定患者群体中检测到 BC 手术后早期和晚期的损伤。